New NZ-Australian mRNA-based vaccine could be a gamechanger for malaria
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out
more.
We are serious about journalism.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Or use the information you’ve already given Google to create your subscription.
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
NZ sharemarket reacts positively to GDP news
The S&P/NZX 50 Index closed at 12,054.72, up 8.79 points or 0.073%.
Energy minister out to avert another winter power crisis
Simon Watts says hoping for rain is 'not the way to do business'.
Analysts hold mixed hopes for retailers ahead of earnings
Forsyth Barr likes the look of Hallenstein Glasson.
The new face of luxury Scotch: Harrison Ford, the Traitors castle and an E-Type Jag
Harrison Ford’s Glenmorangie campaign breaks all the rules.
Mastering market swings
ETFs can be a "smart" way to build a long-term, diverse portfolio.
